As of 2024-12-15, the EV/EBITDA ratio of Moderna Inc (MRNA) is -8.36. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MRNA's latest enterprise value is 15,108.02 mil USD. MRNA's TTM EBITDA according to its financial statements is -1,808.00 mil USD. Dividing these 2 quantities gives us the above MRNA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.5x - 22.2x | 14.6x |
| Forward P/E multiples | 11.3x - 15.4x | 13.3x |
| Fair Price | (51.65) - (69.78) | (62.97) |
| Upside | -223.5% - -266.8% | -250.5% |
| Date | EV/EBITDA |
| 2024-12-13 | -8.36 |
| 2024-12-12 | -8.57 |
| 2024-12-11 | -8.58 |
| 2024-12-10 | -8.29 |
| 2024-12-09 | -9.17 |
| 2024-12-06 | -8.91 |
| 2024-12-05 | -8.59 |
| 2024-12-04 | -8.31 |
| 2024-12-03 | -8.52 |
| 2024-12-02 | -8.87 |
| 2024-11-29 | -8.62 |
| 2024-11-27 | -8.69 |
| 2024-11-26 | -8.40 |
| 2024-11-25 | -8.75 |
| 2024-11-22 | -8.20 |
| 2024-11-21 | -7.59 |
| 2024-11-20 | -7.32 |
| 2024-11-19 | -7.39 |
| 2024-11-18 | -7.86 |
| 2024-11-15 | -7.30 |
| 2024-11-14 | -7.92 |
| 2024-11-13 | -8.42 |
| 2024-11-12 | -8.71 |
| 2024-11-11 | -8.55 |
| 2024-11-08 | -9.42 |
| 2024-11-07 | -10.15 |
| 2024-11-06 | -10.48 |
| 2024-11-05 | -10.80 |
| 2024-11-04 | -10.85 |
| 2024-11-01 | -11.08 |
| 2024-10-31 | -11.02 |
| 2024-10-30 | -11.10 |
| 2024-10-29 | -11.21 |
| 2024-10-28 | -11.12 |
| 2024-10-25 | -10.75 |
| 2024-10-24 | -10.69 |
| 2024-10-23 | -10.82 |
| 2024-10-22 | -10.82 |
| 2024-10-21 | -10.90 |
| 2024-10-18 | -10.97 |
| 2024-10-17 | -11.12 |
| 2024-10-16 | -11.68 |
| 2024-10-15 | -11.65 |
| 2024-10-14 | -11.74 |
| 2024-10-11 | -11.86 |
| 2024-10-10 | -11.55 |
| 2024-10-09 | -11.98 |
| 2024-10-08 | -11.88 |
| 2024-10-07 | -11.95 |
| 2024-10-04 | -12.27 |